Phase Holographic Imaging (PHI), a medical technology company specializing in non-invasive cell imaging, has announced its listing on the OTCQB Venture Market in the US. This move aims to enhance accessibility for US investors and facilitate more transparent trading, supporting PHI’s growth in the regenerative medicine field.